# A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects

> **NCT07633691** · PHASE1 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Healthy Adult

## Interventions

- **DRUG:** DA-5223-R
- **DRUG:** DA-5223-F
- **DRUG:** DA-5223-M

## Key facts

- **NCT ID:** NCT07633691
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-06-15
- **Primary completion:** 2026-06-23
- **Final completion:** 2026-07-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07633691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07633691, "A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07633691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*